rivaroxaban 2.5 MG Oral Tablet
- RxCUI
- 2059015
- RxNorm name
- rivaroxaban 2.5 MG Oral Tablet
- Display name
- rivaroxaban 2.5 MG Oral Tablet
- Full name
- rivaroxaban 2.5 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RIVAROXABAN | RIVAROXABAN | Micro Labs Limited | 481b7802-5093-43e7-bbd9-1532197eb6e6 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | ScieGen pharmaceuticals,Inc | 3b53cebf-946c-b82b-e063-6394a90a5da7 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | NorthStar RxLLC | 88246a0e-befe-4dc6-81e1-4b7adc266db2 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Sun Pharmaceutical Industries, Inc. | 925a9a11-ae5b-405c-96d2-b1be4b85bf71 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Aurobindo Pharma Limited | bcb0e6e7-3006-4d82-8009-c5fddbbfc80d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Dr.Reddy's Laboratories, Inc. | 122e6f78-067b-9065-adb2-ec7fec9f008e | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Apotex Corp. | e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| RIVAROXABAN | RIVAROXABAN | Alembic Pharmaceuticals Inc. | e62f23c6-89f2-4179-95dc-5732401b3f93 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| RIVAROXABAN | RIVAROXABAN | Lupin Pharmaceuticals, Inc. | 702fed3e-ae25-49ba-98cc-562e0e244214 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Macleods Pharmaceuticals Limited | 57717a31-d9d3-4246-90c0-4e4c0a29adf5 | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Novadoz Pharmaceuticals LLC | e8e4275c-6cbe-4976-8cae-f62baf954d27 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Xarelto | RIVAROXABAN | Janssen Pharmaceuticals, Inc. | 10db92f9-2300-4a80-836b-673e1ae91610 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Indoco Remedies Limited | 9fee7136-c8fd-4bea-ab15-7a0e7292396d | 2025-11-28 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| RIVAROXABAN | RIVAROXABAN | Alembic Pharmaceuticals Limited | 5524f30f-789d-4f5c-8f7c-d03a475b6d34 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| rivaroxaban | RIVAROXABAN | Florida Pharmaceutical Products, LLC | f0ef9361-f06d-4028-97af-183b545f4aea | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| RIVAROXABAN | RIVAROXABAN | XLCare Pharmaceuticals, Inc. | 291011aa-60eb-4109-b59c-1c521fbeac4f | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| Rivaroxaban | RIVAROXABAN | Exelan pharmaceuticals,Inc | c2f55475-2a98-43f3-9eac-93995904ebc5 | 2025-06-01 | Boxed warning, Warnings, Adverse reactions | 2059015 |
| RIVAROXABAN | RIVAROXABAN | Camber Pharmaceuticals, Inc. | 45f16f1b-e405-4aa6-bc8b-977d4864af3e | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | 2059015 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 10db92f9-2300-4a80-836b-673e1ae91610 | rivaroxaban 2.5 MG Oral Tablet | PSN | 64 | These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 2011 | 20260116 |
| 10db92f9-2300-4a80-836b-673e1ae91610 | rivaroxaban 2.5 MG Oral Tablet | SCD | 64 | These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 2011 | 20260116 |
| 925a9a11-ae5b-405c-96d2-b1be4b85bf71 | rivaroxaban 2.5 MG Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260527 |
| 925a9a11-ae5b-405c-96d2-b1be4b85bf71 | rivaroxaban 2.5 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260527 |
| 702fed3e-ae25-49ba-98cc-562e0e244214 | rivaroxaban 2.5 MG Oral Tablet | SCD | 14 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260408 |
| 702fed3e-ae25-49ba-98cc-562e0e244214 | rivaroxaban 2.5 MG Oral Tablet | PSN | 14 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260408 |
| 122e6f78-067b-9065-adb2-ec7fec9f008e | rivaroxaban 2.5 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS . RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260429 |
| 122e6f78-067b-9065-adb2-ec7fec9f008e | rivaroxaban 2.5 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS . RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260429 |
| e62f23c6-89f2-4179-95dc-5732401b3f93 | rivaroxaban 2.5 MG Oral Tablet | SCD | 7 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20251017 |
| e62f23c6-89f2-4179-95dc-5732401b3f93 | rivaroxaban 2.5 MG Oral Tablet | PSN | 7 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20251017 |
| bcb0e6e7-3006-4d82-8009-c5fddbbfc80d | rivaroxaban 2.5 MG Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260507 |
| bcb0e6e7-3006-4d82-8009-c5fddbbfc80d | rivaroxaban 2.5 MG Oral Tablet | SCD | 5 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260507 |
| 57717a31-d9d3-4246-90c0-4e4c0a29adf5 | rivaroxaban 2.5 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260406 |
| 57717a31-d9d3-4246-90c0-4e4c0a29adf5 | rivaroxaban 2.5 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260406 |
| e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd | rivaroxaban 2.5 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260417 |
| e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd | rivaroxaban 2.5 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260417 |
| 9fee7136-c8fd-4bea-ab15-7a0e7292396d | rivaroxaban 2.5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. Rivaroxaban tablets, for oral use Initial U.S. Approval: 2011 | 20251128 |
| 9fee7136-c8fd-4bea-ab15-7a0e7292396d | rivaroxaban 2.5 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. Rivaroxaban tablets, for oral use Initial U.S. Approval: 2011 | 20251128 |
| 5524f30f-789d-4f5c-8f7c-d03a475b6d34 | rivaroxaban 2.5 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20251121 |
| 5524f30f-789d-4f5c-8f7c-d03a475b6d34 | rivaroxaban 2.5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20251121 |
| e8e4275c-6cbe-4976-8cae-f62baf954d27 | rivaroxaban 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260318 |
| e8e4275c-6cbe-4976-8cae-f62baf954d27 | rivaroxaban 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20260318 |
| f0ef9361-f06d-4028-97af-183b545f4aea | rivaroxaban 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250819 |
| f0ef9361-f06d-4028-97af-183b545f4aea | rivaroxaban 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250819 |
| 3b53cebf-946c-b82b-e063-6394a90a5da7 | rivaroxaban 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250801 |
| 3b53cebf-946c-b82b-e063-6394a90a5da7 | rivaroxaban 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250801 |
| 291011aa-60eb-4109-b59c-1c521fbeac4f | rivaroxaban 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250617 |
| 291011aa-60eb-4109-b59c-1c521fbeac4f | rivaroxaban 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250617 |
| c2f55475-2a98-43f3-9eac-93995904ebc5 | rivaroxaban 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250601 |
| c2f55475-2a98-43f3-9eac-93995904ebc5 | rivaroxaban 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250601 |
| 45f16f1b-e405-4aa6-bc8b-977d4864af3e | rivaroxaban 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250517 |
| 45f16f1b-e405-4aa6-bc8b-977d4864af3e | rivaroxaban 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS. RIVAROXABAN tablets, for oral use Initial U.S. Approval: 2011 | 20250517 |